Acute ergotropic response induced by reserpine and mephentermine.
D006916:5-Hydroxytryptophan / Q000378:metabolism*; D000818:Animals; D001522:Behavior, Animal; D001921:Brain / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use; D003674:Defense Mechanisms / Q000139:chemically induced*; D004295:Dihydroxyphenylalanine / Q000378:metabolism*; D004285:Dogs; D004298:Dopamine / Q000378:metabolism*; D004357:Drug Synergism; D004569:Electroencephalography; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D007490:Iproniazid / Q000627:therapeutic use; D008616:Mephentermine / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism*; D010424:Pentobarbital; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology*; D012601:Scopolamine / Q000627:therapeutic use; D014443:Tyrosine / Q000627:therapeutic use
D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D006916:5-Hydroxytryptophan; D007490:Iproniazid; D012601:Scopolamine; D010424:Pentobarbital; D007099:Imipramine; D008616:Mephentermine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine